“The team focused on cell and gene therapy at ADVI has the expertise that is required and necessary to understand the nuances of bringing products to market.”
Cell and Gene
Successful cell or gene therapy coverage and reimbursement requires a nuanced, multidisciplinary approach. It also requires deep knowledge in policy, pricing, and access – oftentimes alongside the right partner.
ADVI Health is a trailblazer with critical commercial launch preparation for cell and gene therapies that help treat, prevent, or cure a wide array of untreatable and difficult-to-treat diseases. We help our clients navigate the federal and state policy landscape, highlight unique value drivers, and advocate to critical stakeholders across the healthcare landscape and pride ourselves in the ability to achieve positive results.
We are your go-to partner for strategy, policy updates, data analytics and value economics in cell and gene therapies, rare and ultra-rare diseases, and oncology therapeutics, devices, and diagnostics.
Explore the latest resources and up-to-date information on cell and gene, implications for the industry, and insights on recent updates.
ADVI Health partnered with Alliance for Regenerative Medicine to review Medicaid access barriers in cell and gene therapies. Review the key findings and read the full white paper
(December 28, 2023)
Marc Samuels Discusses Insights on the Evolving Landscape
Shares his perspectives on the Inflation Reduction Act, CMMI, MedPAC, and developments impacting patient access for CAR T-cell therapy for solid tumors and sickle cell therapies.
(January 12, 2023)
“Things are moving very quickly in cell and gene therapy, but ultimately that is a good thing. Our job is to find solutions and get the right people in the right places to get products in position for commercialization success.”
Alicia Silver, Director of Health Policy and Reimbursement
Seize The Opportunity
Submit an RFP
Submit an RFP and let’s determine how our team of experts can support your business.
Market Access and Pricing Strategy
We help your best ideas become market leaders. Regardless of where you are in the product life cycle, we can take it to the next level. We create and communicate value, accelerate growth, optimize access, and confidently navigate the shifting market landscape.
Federal And State Policy
Our team monitors qualitative and quantitative trends and policy and legislation in real time. We create customized models to inform successful strategies and tactics so you can act decisively.
Strategic Analytics. Value and Economics
Your product must pass muster with payers. We help you define, measure, and report value across settings of care, prospective payment systems, and insurance benefit structures.
Coding and Reimbursement
Understanding Medicare, Medicaid, VA-DOD, and private payers is vital. There is no easy button. We help you stay ahead of changing regulations and ensure you are prepared for what’s next.
Financial Services Due Diligence
Thinking like investors, we deliver customized, deep, data-driven analysis to quantify relevant risks, opportunities, and trends to inform financial models and recommend how to achieve goals.